Laurus Labs Ltd.

Gilead Sciences, Inc. ’s voluntary licensing (VL) agreements for lenacapavir may have managed to take some of the sting out of the patent opposition case in India but health groups and activists don’t

The BIOSECURE Act, when enacted, could leave some US pharma firms with pretty big shoes to fill given that it will strip the supply pool of WuXi AppTec Inc. , WuXi Biologics , Complete Genomics Inc

Gilead Sciences, Inc. ’s voluntary licensing (VL) agreements for lenacapavir may have managed to take some of the sting out of the patent opposition case in India but health groups and activists don’t

MSN Laboratories’ US Food and Drug Administration approval for its generic version of Novartis’ multi-billion-dollar heart failure drug Entresto (sacubitril/valsartan) has been stayed for now by a Wa